X4 Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
X4 Pharmaceuticals, Inc.‘s stocks are currently a part of 34 hedge funds’ portfolios, which represents 10.95% of the total amount of its stocks outstanding. This makes up a total of 6.95M shares of X4 Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -88.52% or -53.65M shares fewer. As for the holding position changes, 26.47% (9) of current hedge fund investors increased the number of shares held, 14.71% (5) of current holders sold a part of the shares held, and 14.71% (5) closed the holdings completely. 10 hedge funds are new holders of X4 Pharmaceuticals, Inc. stock in Q1 2023, it is 29.41% of total holders.
Hedge funds holding X4 Pharmaceuticals (Q1 2019 – Q1 2023)
| Q1 2019 | 29 |
|---|---|
| Q2 2019 | 43 |
| Q3 2019 | 49 |
| Q4 2019 | 54 |
| Q1 2020 | 50 |
| Q2 2020 | 56 |
| Q3 2020 | 51 |
| Q4 2020 | 53 |
| Q1 2021 | 60 |
| Q2 2021 | 60 |
| Q3 2021 | 50 |
| Q4 2021 | 50 |
| Q1 2022 | 53 |
| Q2 2022 | 44 |
| Q3 2022 | 54 |
| Q4 2022 | 51 |
| Q1 2023 | 34 |
Hedge funds changes in X4 Pharmaceuticals positions (Q1 2019 – Q1 2023)
| Q1 2019 | 29 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 18 | 20 | 1 | 3 | 1 |
| Q3 2019 | 9 | 25 | 7 | 3 | 5 |
| Q4 2019 | 14 | 24 | 6 | 4 | 6 |
| Q1 2020 | 7 | 18 | 15 | 11 | -1 |
| Q2 2020 | 16 | 17 | 12 | 10 | 1 |
| Q3 2020 | 3 | 18 | 18 | 8 | 4 |
| Q4 2020 | 6 | 21 | 13 | 4 | 9 |
| Q1 2021 | 12 | 19 | 15 | 5 | 9 |
| Q2 2021 | 18 | 8 | 17 | 18 | -1 |
| Q3 2021 | 6 | 8 | 21 | 16 | -1 |
| Q4 2021 | 13 | 11 | 14 | 11 | 1 |
| Q1 2022 | 9 | 12 | 15 | 6 | 11 |
| Q2 2022 | 5 | 11 | 9 | 13 | 6 |
| Q3 2022 | 14 | 17 | 4 | 3 | 16 |
| Q4 2022 | 12 | 18 | 10 | 14 | -3 |
| Q1 2023 | 10 | 9 | 5 | 5 | 5 |
Hedge funds changes in X4 Pharmaceuticals stock options (Q1 2019 – Q1 2023)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 750,000 | 0 |
| Q3 2019 | 636,000 | 0 |
| Q4 2019 | 1,605,000 | 0 |
| Q1 2020 | 1,500,000 | 0 |
| Q2 2020 | 1,398,000 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 167,000 | 0 |
| Q3 2021 | 416,000 | 60,000 |
| Q4 2021 | 266,000 | 421,000 |
| Q1 2022 | 748,000 | 878,000 |
| Q2 2022 | 191,000 | 32,000 |
| Q3 2022 | 123,000 | 221,000 |
| Q4 2022 | 270,816 | 239,407 |
| Q1 2023 | 4,091,000 | 8,804,000 |